GWN Securities Inc. Trims Position in UnitedHealth Group Incorporated $UNH

GWN Securities Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 42.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,154 shares of the healthcare conglomerate’s stock after selling 9,532 shares during the quarter. GWN Securities Inc.’s holdings in UnitedHealth Group were worth $4,214,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the business. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Avidian Wealth Enterprises LLC boosted its holdings in UnitedHealth Group by 1.6% during the first quarter. Avidian Wealth Enterprises LLC now owns 2,449 shares of the healthcare conglomerate’s stock worth $1,283,000 after buying an additional 39 shares in the last quarter. Amalgamated Bank boosted its holdings in UnitedHealth Group by 0.8% during the first quarter. Amalgamated Bank now owns 186,742 shares of the healthcare conglomerate’s stock worth $97,806,000 after buying an additional 1,446 shares in the last quarter. Finally, Northwest Wealth Management LLC raised its position in shares of UnitedHealth Group by 18.4% in the first quarter. Northwest Wealth Management LLC now owns 700 shares of the healthcare conglomerate’s stock worth $367,000 after acquiring an additional 109 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH opened at $365.97 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm’s 50-day moving average price is $339.58 and its 200 day moving average price is $334.29. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market capitalization of $331.45 billion, a PE ratio of 15.86, a PEG ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period last year, the business earned $6.80 earnings per share. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Royal Bank Of Canada cut their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Truist Financial increased their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Mizuho boosted their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.